Inflammation plays an essential role
in the human immune system,
and anti-inflammatory compounds are important to promote health. However,
the in vitro screening of these compounds is largely dependent on
flat biology. Herein, we report our efforts in establishing a 3D inflammation
murine macrophage model. Murine macrophage RAW 264.7 cells were cultured
on poly(ε-caprolactone) (PCL) scaffolds fabricated through an
electrohydrodynamic jetting 3D printer and their behavior were examined.
Cells on PCL scaffolds showed a 3D shape and morphology with multilayers
and a lower proliferation rate. Moreover, macrophages were not activated
by scaffold material PCL and 3D microenvironment. The 3D cells showed
greater sensitivity to lipopolysaccharide stimulation with higher
production activity of nitric oxide (NO), nitric oxide synthases (iNOS),
and cyclooxygenase-2 (COX-2). Additionally, the 3D macrophage model
showed lower drug sensitivity to commercial anti-inflammatory drugs
including aspirin, ibuprofen, and dexamethasone, and natural flavones
apigenin and luteolin with higher IC50 for NO production
and lower iNOS and COX-2 inhibition efficacy. Overall, the 3D macrophage
model showed promise for higher accurate screening of anti-inflammatory
compounds. We developed, for the first time, a 3D macrophage model
based on a 3D-printed PCL scaffold that provides an extracellular
matrix environment for cells to grow in the 3D dimension. 3D-grown
RAW 264.7 cells showed different sensitivities and responses to anti-inflammatory
compounds from its 2D model. The 3D cells have lower sensitivity to
both commercial and natural anti-inflammatory compounds. Consequently,
our 3D macrophage model could be applied to screen anti-inflammatory
compounds more accurately and thus holds great potential in next-generation
drug screening applications.